High-Resolution Computed Tomography and Lung Ultrasound in Patients with Systemic Sclerosis: Which One to Choose?

Imaging plays a pivotal role in systemic sclerosis for both diagnosis management of pulmonary complications, and high-resolution computed tomography (HRCT) is the most sensitive technique for the evaluation of systemic sclerosis-associated interstitial lung disease (SSc-ILD). Indeed, several studies...

Full description

Bibliographic Details
Published in:	Diagnostics
Main Authors:	Barbara Ruaro, Elisa Baratella, Paola Confalonieri, Marco Confalonieri, Fabio Giuseppe Vassallo, Barbara Wade, Pietro Geri, Riccardo Pozzan, Gaetano Caforio, Cristina Marrocchio, Maria Assunta Cova, Francesco Salton
Format:	Article
Language:	English
Published:	MDPI AG 2021-12-01
Subjects:	systemic sclerosis-associated interstitial lung disease (SSc-ILD) interstitial lung disease (ILD) systemic sclerosis (SSc) diagnostic imaging high-resolution computed tomography (HRCT) lung ultrasound (LUS)
Online Access:	https://www.mdpi.com/2075-4418/11/12/2293

Similar Items

High-Resolution Computed Tomography: Lights and Shadows in Improving Care for SSc-ILD Patients
by: Barbara Ruaro, et al.
Published: (2021-10-01)

The diagnostic trajectories of Danish patients with autoimmune rheumatologic disease associated interstitial lung disease: an interview-based study
by: MB Johansen, et al.
Published: (2023-01-01)

Nintedanib in systemic sclerosis treatment: a case report
by: Maysoun Kudsi, et al.
Published: (2024-02-01)

Safety of prolonged use of metoclopramide and domperidone as treatment for chronic gastrointestinal dysmotility disorders in patients with systemic sclerosis
by: Saad Alkhowaiter, et al.
Published: (2024-05-01)

Complications in Idiopathic Pulmonary Fibrosis: Focus on Their Clinical and Radiological Features
by: Federica Galioto, et al.
Published: (2020-07-01)

Diagnostics, Efficacy, and Safety of Immunomodulatory and Anti-Fibrotic Treatment for Interstitial Lung Disease Associated with Systemic Scleroderma (SSc-ILD)
by: Dawid Piecuch, et al.
Published: (2025-09-01)

Macrophages as determinants and regulators of systemic sclerosis-related interstitial lung disease
by: Shih-Ching Lee, et al.
Published: (2024-06-01)

Influence of CT Image Matrix Size and Kernel Type on the Assessment of HRCT in Patients with SSC-ILD
by: Bettina D. Balmer, et al.
Published: (2022-07-01)

Egyptian evidence-based consensus on clinical practice recommendations for the management of systemic sclerosis
by: Yasser El Miedany, et al.
Published: (2024-02-01)

Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy
by: Barbara Ruaro, et al.
Published: (2023-02-01)

Pulmonary function in Thai patients with systemic sclerosis; a single center 6-year retrospective study [version 2; peer review: 1 approved, 2 approved with reservations]
by: Thitisak Sakulvorakitti, et al.
Published: (2024-05-01)

Connective Tissue Disease‑Associated Interstitial Lung Disease (CTD‑ILD)
by: Cindy Mai
Published: (2024-11-01)

Clinical Characterization and Predictive Factors for Progression in a Cohort of Patients with Interstitial Lung Disease and Features of Autoimmunity: The Need for a Revision of IPAF Classification Criteria
by: Francesco Bozzao, et al.
Published: (2023-04-01)

Biomarkers in Systemic Sclerosis: An Overview
by: Giuseppe Di Maggio, et al.
Published: (2023-09-01)

Anti-U11/U12 Antibodies as a Rare but Important Biomarker in Patients with Systemic Sclerosis: A Narrative Review
by: Marvin J. Fritzler, et al.
Published: (2023-03-01)

Correlation between Microvascular Damage and Internal Organ Involvement in Scleroderma: Focus on Lung Damage and Endothelial Dysfunction
by: Mario D’Oria, et al.
Published: (2022-12-01)

Interstitial lung abnormality (ILA) and nonspecific interstitial pneumonia (NSIP)
by: Takuya Hino, et al.
Published: (2021-01-01)

Beyond Visual Interpretation: Quantitative Analysis and Artificial Intelligence in Interstitial Lung Disease Diagnosis “Expanding Horizons in Radiology”
by: Gaetano Rea, et al.
Published: (2023-07-01)

Pulmonary Nodules in Juvenile Systemic Sclerosis: A Case-Series from the National Registry for Childhood Onset Scleroderma (NRCOS)
by: Jonathan C. Li, et al.
Published: (2023-06-01)

Editorial: Pulmonary fibrosis: One manifestation, various diseases
by: Barbara Ruaro, et al.
Published: (2022-10-01)

Comparing clinical characteristics of systemic sclerosis with or without interstitial lung disease: A cross-sectional study from a single center of the Chinese Rheumatism Data Center
by: Haoguang Li, et al.
Published: (2022-12-01)

Role of high resolution comp
by: Youssriah Y. Sabri, et al.
Published: (2016-09-01)

Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat?
by: Barbara Ruaro, et al.
Published: (2022-08-01)

Nintedanib combined with immunosuppressive agents improves forced vital capacity in connective tissue disease-associated PF-ILD: a single-center study
by: Yusuke Ushio, et al.
Published: (2024-06-01)

Lung ultrasound for assessing disease progression in UIP and NSIP: a comparative study with HRCT and PFT/DLCO
by: Nasrollahzadeh Milad, et al.
Published: (2025-01-01)

Exploring the common pathophysiological links between IPF, SSc-ILD and post-COVID fibrosis
by: Rajesh Swarnakar, et al.
Published: (2022-01-01)

Evaluation of Correlations between Genetic Variants and High-Resolution Computed Tomography Patterns in Idiopathic Pulmonary Fibrosis
by: Elisa Baratella, et al.
Published: (2021-04-01)

The Relationship between Pulmonary Damage and Peripheral Vascular Manifestations in Systemic Sclerosis Patients
by: Barbara Ruaro, et al.
Published: (2021-04-01)

Cystic lung lesion following transbronchial lung cryobiopsy: Case report and systematic review
by: Srikant Kashinath Malegaonkar, et al.
Published: (2023-01-01)

Childhood interstitial lung disease: When to suspect and what to do
by: Grazia Fenu, et al.
Published: (2024-06-01)

Efficacy and Safety of Nintedanib in Patients with Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD): A Real-World Single Center Experience
by: Maria Boutel, et al.
Published: (2023-03-01)

Spectrum of autoantibodies and other serological parameters in connective tissue disease–associated interstitial lung disease patients
by: Pooja Jaiswal, et al.
Published: (2026-06-01)

Comparison of rituximab vs. cyclophosphamide in rheumatoid arthritis-associated interstitial lung disease and its correlation with spirometry
by: Mohammed Abdullah Saleem, et al.
Published: (2024-12-01)

A 2-year-old girl with chronic crackles after respiratory syncytial virus infection: a case report
by: Katarzyna Woicka-Kolejwa, et al.
Published: (2018-09-01)

Functional Progression after Dose Suspension or Discontinuation of Nintedanib in Idiopathic Pulmonary Fibrosis: A Real-Life Multicentre Study
by: Barbara Ruaro, et al.
Published: (2024-01-01)

Outcomes and Incidence of PF-ILD According to Different Definitions in a Real-World Setting
by: Sebastiano Emanuele Torrisi, et al.
Published: (2021-12-01)

Fibroblasts in rheumatoid arthritis: novel roles in joint inflammation and beyond
by: Elpida Neofotistou-Themeli, et al.
Published: (2025-01-01)

Diagnostic yield and risk/benefit analysis of trans-bronchial lung cryobiopsy in diffuse parenchymal lung diseases: a large cohort of 699 patients
by: Claudia Ravaglia, et al.
Published: (2019-01-01)

Clinical Impact of Vertical Artifacts Changing with Frequency in Lung Ultrasound
by: Natalia Buda, et al.
Published: (2021-02-01)

Children’s Interstitial and Diffuse Lung Diseases (ChILD) in 2020
by: Valentina Agnese Ferraro, et al.
Published: (2020-12-01)